Literature DB >> 8641027

Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.

J Frielingsdorf1, C Seiler, P Kaufmann, G Vassalli, T Suter, O M Hess.   

Abstract

BACKGROUND: Endothelial dysfunction with a loss of endothelium-dependent vasodilation has been reported in patients with arterial hypertension. The purpose of the present study was to evaluate coronary vasomotor response to dynamic exercise in patients with coronary artery disease with and without arterial hypertension and to determine the effect of calcium antagonists on coronary vasomotion. METHODS AND
RESULTS: Cross-sectional areas of a normal and a stenotic coronary vessel segment were examined in 79 patients with coronary artery disease at rest and during supine bicycle exercise (Ex). Change in luminal area after acute administration of a calcium antagonist (diltiazem or nicardipine), during exercise, and after sublingual nitroglycerin (percent change compared with rest = 100%) was assessed by biplane quantitative coronary arteriography. Patients were divided into two groups: Group 1 (control) consisted of 48 patients without (normotensive subjects, n = 30; hypertensive subjects, n = 18) and group 2 of 31 patients with (normotensive subjects, n = 15; hypertensive subjects, n = 16) pretreatment with a calcium antagonist immediately before exercise. The groups did not differ with regard to clinical characteristics or hemodynamic data measured during exercise. Mean aortic pressure at rest, however, was significantly increased in hypertensive patients compared with normotensive subjects in group 1 (103 mm Hg versus 92 mm Hg, P < .01) and group 2 (110 mm Hg versus 98 mm Hg, P < .025). In group 1, exercise-induced vasomotor response was significantly different between normotensive and hypertensive patients in normal (+20% versus +1%, P < .003) and stenotic vessels (-5% versus -20%, P < .025). However, in group 2 there was coronary vasodilation in normotensive and hypertensive patients for both normal (delta Ex +23% versus +21%, P = NS) and stenotic vessel segments (+24% versus +26%, P = NS).
CONCLUSIONS: Abnormal coronary vasomotion during exercise can be observed in hypertensive patients with reduced vasodilator response in normal arteries and enhanced vasoconstrictor response in stenotic arteries. Calcium antagonists prevent the abnormal response of normal and stenotic coronary arteries to exercise in hypertensive patients and thus may compensate for endothelial dysfunction with reduced vasodilator response to exercise.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641027     DOI: 10.1161/01.cir.93.7.1380

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension.

Authors:  T Santoso
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 3.  Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease.

Authors:  J D Schuijf; D Poldermans; L J Shaw; J W Jukema; H J Lamb; A de Roos; W Wijns; E E van der Wall; J J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01       Impact factor: 9.236

4.  Effects of antihypertensive treatment on endothelial function.

Authors:  Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

5.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

6.  Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients.

Authors:  N Hutri-Kähönen; M Kähönen; X Wu; J Sand; I Nordback; J Taurio; I Pörsti
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 7.  How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?

Authors:  S Jost; C W Nolte; M Sturm; J Hausleiter; D Hausmann
Journal:  Int J Card Imaging       Date:  1998-12

Review 8.  Coronary endothelial function in health and disease.

Authors:  J C Burnett
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 9.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

Review 10.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.